Efficacy of combination therapy with GABA, a DPP-4i and a PPI as an adjunct to insulin therapy in patients with type 1 diabetes

por Rabinovitch, Alexander, Koshelev, Daniil, Lagunas-Rangel, Francisco Alejandro, Kosheleva, Liudmila, Gavra, Tali, Schiöth, Helgi B., Levit, Shmuel
Publicado 2023

Triple drug therapy with GABA, sitagliptin, and omeprazole prevents type 1 diabetes onset and promotes its reversal in non-obese diabetic mice

por Lagunas-Rangel, Francisco Alejandro, Koshelev, Daniil, Nedorubov, Andrej, Kosheleva, Liudmila, Trukhan, Vladimir, Rabinovitch, Alexander, Schiöth, Helgi B., Levit, Shmuel
Publicado 2022